Investing Profile

Maha Katabi

InvestorVC
General Partner at Sofinnova Investments
Photo of Maha Katabi, General Partner at Sofinnova Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Sofinnova Investments General Partner
$100K - $5.0M
$1.5M
12
CompanyStageDateRound SizeTotal Raised
Marea Therapeutics
Series BJun 2024$190M
$260M
Co-investors: Charles Homcy (Third Rock Ventures), Jeffrey Tong (Third Rock Ventures), Aaron Royston (venBio), Chris Garabedian (Perceptive Advisors)
Star Therapeutics
Series CSep 2023$90M
$90M
Co-investors: Carl Gordon (OrbiMed), Beth Seidenberg (Westlake Village BioPartners)
Quanta Therapeutics
Series DMay 2023$51M
$110M
Co-investors: Arjun Goyal (Vida Ventures)
RayzeBio
Series DSep 2022$160M
$420M
Co-investors: Aaron Royston (venBio), bong koh (KohFounders), Jerel Davis (Versant Ventures), Bong Koh (Venrock)
Gyroscope Therapeutics
Series CMar 2021$150M
$210M
Co-investors: Robert Tansley (Cambridge Innovation Capital), Wouter Joustra (Forbion), Dmitrij Hristodorov (Forbion)
Vera Therapeutics
Series CJan 2021$80M
Series UnknownJan 2020
$110M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Beth Seidenberg (Westlake Village BioPartners), Kurt von Emster (Abingworth)
Aerovate Therapeutics
Series AAug 2020$73M
$73M
Apellis Pharmaceuticals
Series EAug 2017$60M
$60M